Katherine Taylor, Head of External Affairs and Acting Chief Executive, Ovarian Cancer Action said:
"Leela has the rare ability to digest complex information and turn it into stimulating, accessible and relevant material. She addresses challenges with originality and insight, and thinks creatively about what can best help an organisation. She's not afraid of giving honest feedback but is always a pleasure to work with"
Helen Gordon, Deputy Director of Workforce, Guy's and St Thomas' NHS Foundation Trust said:
"Leela undertook for us a very rapidly commissioned detailed and thorough evaluation of our complicated programme of work on health and wellbeing, over a very short and challenging timescale. The measures and quantifiable data in her very professional report were complemented by a thoughtful, pragmatic and sensible series of reflections and wider contributions. I would recommend her highly"
Simon Davies, formerly Chairman of Cancer52 and Chief Executive Officer of the Teenage Cancer Trust said:
"Leela is a class act. We found the thoroughness of her research, the quality of her insight, and her comprehensive reporting, excellent value for money. I wouldn't hesitate to recommend her"
Graham Minton, formerly Director of Corporate Relations, World Heart Federation said:
"Leela was a huge asset to our project, she was highly efficient, focused and detailed. As a result she helped us tailor the research approach and produce an excellent report, which produced very good coverage. Leela was a pleasure to work with, and always delivers first class work"
James Beeby, formerly Head of Corporate Partnerships, The Stroke Alliance for Europe said:
"We commissioned Leela to research and write a European report about the state of Atrial Fibrillation services across Europe and were very pleased with the results. Leela worked thoroughly and with authority to produce a report which has been a very useful resource for the Stroke Alliance for Europe. In addition, she was a pleasure to work with, always working to deadlines, and with an easy and approachable manner at all times"
Christine Hancock, Founder of C3 Collaborating for Health said:
"It was a pleasure working with Leela, she was able to take a vast literature and identify insights in a way that meant that they were accessible to all"
Mark Bassett, Consultant World Bank Group and formerly Director of Public Policy, BUPA Group said:
"I am very happy to commend Leela's work which I have always found thorough, rigorous, incisive and well presented"
Lara Dow, Head of European Communications, Mundipharma International Limited, said:
"Leela is efficient, flexible and always provides a professional service. She is thorough in her research, providing strategic insight and clear but detailed reports. A pleasure to work with and highly recommended"
Lara Dow, Head of European Communications, Mundipharma International Limited, said:
"Leela is efficient, flexible and always provides a professional service. She is thorough in her research, providing strategic insight and clear but detailed reports. A pleasure to work with and highly recommended"
Dave Ryner, Head of Policy at Cancer52, said:
"Leela is a health economist who is well aware that the measurable and quantifiable are not the whole story. Unlike many of her fellow professionals, she perceives critically the interplay between an economics orientated analysis and wider health policy development.
Even better, she possesses a developed eye and ear for what a more holistic analysis might look like over the horizon. In short, Leela is very much like the Second Coming for any astute patient organisation especially as her words arrive without the need to be deciphered from the orthodoxy of health economics speak"
Public and Policy Affairs Executive working at a global research based pharmaceutical company, said:
"It has been an absolute pleasure working with you, you really are excellent at what you do"
A Market Access Director at a global research based pharmaceutical company said about an Advisory Board:
"one our our best discussions at an Ad Board"
An Executive Director at a global research based pharmaceutical said about an Advisory Board:
"Many thanks for a great job today, the participants were well researched and first class - a good mix of regulatory, competition and health economics...the discussion was helpful and informative...participants praised the succinct briefing material and organisation"
